Flicker Fusion
Hypnotics and Sedatives
Psychomotor Performance
Anti-Anxiety Agents
Double-Blind Method
Membrane Fusion
Why and how is soft copy reading possible in clinical practice? (1/306)
The properties of the human visual system (HVS) relevant to the diagnostic process are described after a brief introduction on the general problems and advantages of using soft copy for primary radiology interpretations. At various spatial and temporal frequencies the contrast sensitivity defines the spatial resolution of the eye-brain system and the sensitivity to flicker. The adaptation to the displayed radiological scene and the ambient illumination determine the dynamic range for the operation of the HVS. Although image display devices are determined mainly by state-of-the-art technology, analysis of the HVS may suggest technical characteristics for electronic displays that will help to optimize the display to the operation of the HVS. These include display size, spatial resolution, contrast resolution, luminance range, and noise, from which further consequences for the technical components of a monitor follow. It is emphasized that routine monitor quality control must be available in clinical practice. These image quality measures must be simple enough to be applied as part of the daily routine. These test instructions might also serve as elements of technical acceptance and constancy tests. (+info)Temporal analysis of the chromatic flash VEP--separate colour and luminance contrast components. (2/306)
Temporal analysis of the chromatic flash visual evoked potential (VEP) was studied in human subjects with normal and anomalous colour vision using a deterministic pseudo-random binary stimulus (VERIS). Five experiments were carried out on four normal subjects investigating heterochromatic red-green exchange and single colour/achromatic (either red/grey or green/grey) exchange over a wide range of luminance ratios for the two stimuli, the effects of lowered mean luminance on the chromatic VEP and the effects of colour desaturation at constant mean luminance and constant luminance contrast. Finally, the performance of three dichromats, a protanope and two deuteranopes, on heterochromatic exchange VEP and on colour desaturation were investigated. In contrast to the chromatic electroretinogram, which shows great symmetry with respect to luminance ratio on opposite sides of the isoluminant point, the chromatic VEP demonstrated a distinct asymmetry when the colours exchanged included red. On the red side of isoluminance (red more luminant than green), a wave with longer latency and altered waveform became dominant. The effects of green stimulation were indistinguishable from those of achromatic stimulation at the same luminance contrast over the whole range of chromatic contrast and for all levels of desaturation studied. Desaturation of red with constant luminance contrast (desaturated red/grey stimulation) resulted in a systematic alteration in the evoked waveform. Subtraction of the achromatic first- and second-order responses from responses recorded in the red desaturation series resulted in remarkably uniform waveforms, with peak amplitudes growing linearly with saturation. The absence of interaction between achromatic and coloured components for all (including the most intense colour) stimulus parameters used suggests that the generators of these components are separate. Recordings from the dichromats showed that the contrast response minimum shifted from the point of photopic isoluminance to the point of zero cone contrast (at the silent substitution point) for the remaining cone type. The waveforms recorded with a series of luminance ratios were much simpler than those recorded from trichromats and symmetrical with respect to their isoluminant points. Despite the indication of the presence of L cones of apparently normal spectral sensitivity in the deuteranopes (on the basis of flicker photometry), there was no evidence for a red-sensitive component in the desaturation or heterochromatic stimulation series. The results are discussed in terms of the possibility of separate generation of chromatic and achromatic contributions to the VEP. (+info)S-cone signals to temporal OFF-channels: asymmetrical connections to postreceptoral chromatic mechanisms. (3/306)
Psychophysical tests of S-cone contributions to temporal ON- and OFF-channels were conducted. Detection thresholds for S-cone modulation were measured with two kinds of test stimuli presented on a CRT: a rapid-on sawtooth test and a rapid-off sawtooth test, assumed to be detected differentially by temporal ON- and OFF-channels, respectively. S-cone related ON- and OFF-temporal responses were separated by adapting for 5 min to 1 Hz monochromatic (420, 440, 450, 540, or 650 nm in separate sessions) sawtooth flicker presented in Maxwellian view. Circular test stimuli, with a sawtooth temporal profile and a Gaussian spatial taper, were presented for 1 s in one of four quadrants 1.0 degree from a central fixation point. A four-alternative forced-choice method combined with a double-staircase procedure was used to determine ON- and OFF-thresholds in the same session. Following adaptation, the threshold elevation was greater if the polarity of the test stimulus was the same as the polarity of the sawtooth adaptation flicker, consistent with separate ON- and OFF-responses from S-cones. This asymmetrical pattern was obtained, however, only when the adaptation stimuli appeared blue with a little redness. When the adaptation flicker had a clear reddish hue component, the threshold elevation did not depend on the polarity of the sawtooth test stimuli. These results are consistent with a model in which OFF-signals originating from S cones are maintained by a postreceptoral mechanism signaling redness, but not by a postreceptoral chromatic mechanism signaling blueness. (+info)The effects of temporal noise and retinal illuminance on foveal flicker sensitivity. (4/306)
We measured foveal flicker sensitivity with and without external added temporal noise at various levels of retinal illuminance and described the data with our model of flicker sensitivity comprising: (i) low-pass filtering of the flickering signal plus external temporal and/or quantal noise by the modulation transfer function (MTF) of the retina (R): (ii) high-pass filtering in proportion to temporal frequency by the MTF of the postreceptoral neural pathways (P): (iii) addition of internal white neural noise; and (iv) detection by a temporal matched filter. Without temporal noise flicker sensitivity had a band-pass frequency-dependence at high and medium illuminances but changed towards a low-pass shape above 0.5 Hz at low luminances, in agreement with earlier studies. In strong external temporal noise, however, the flicker sensitivity function had a low-pass shape even at high and medium illuminances and flicker sensitivity was consistently lower with noise than without. At low luminances flicker sensitivity was similar with and without noise. An excellent fit of the model was obtained under the assumption that the only luminance-dependent changes were increases in the cut-off frequency (fc) and maximum contrast transfer of R with increasing luminance. The results imply the following: (i) performance is consistent with detection by a temporal matched filter, but not with a thresholding process based on signal amplitude; (ii) quantal fluctuations do not at any luminance level become a source of dominant noise present at the detector; (iii) the changes in the maximum contrast transfer reflect changes in retinal gain, which at low to moderate luminances implement less-than-Weber adaptation, with a 'square-root' law at the lowest levels; (iv) the changes of fc as function of mean luminance closely parallels time scale changes in cones, but the absolute values of fc are lower than expected from the kinetics of monkey cones at all luminances; (v) the constancy of the high-pass filtering function P indicates that surround antagonism does not weaken significantly with decreasing light level. (+info)Development of spatial and temporal vision during childhood. (5/306)
Using the method of limits, we measured the development of spatial and temporal vision beginning at 4 years of age. Participants were adults, and children aged 4, 5, 6, and 7 years (n = 24 per age). Spatial vision was assessed with vertical sine-wave gratings, and temporal vision was assessed with an unpatterned luminance field sinusoidally modulated over time. Under these testing conditions, spatial contrast sensitivity at every frequency increased by at least 0.5 log units between 4 and 7 years of age, at which point it was adult-like. Grating acuity reached adult values at 6 years of age. Temporal vision was more mature: at 4 years of age temporal contrast sensitivity at higher temporal frequencies (20 and 30 Hz) and critical flicker fusion frequency were already adult-like. Sensitivity at lower temporal frequencies (5 and 10 Hz) increased by 0.25 log units after the age of 4 to reach adult levels at age 7. The results suggest that temporal vision matures more rapidly than spatial vision during childhood. Thus, spatial and temporal vision are likely mediated by different underlying neural mechanisms that mature at different rates. (+info)Pattern electrical stimulation of the human retina. (6/306)
Experiments were conducted to study if electrical stimulation of the retinal surface can elicit visual sensation in individuals blind from end-stage retinitis pigmentosa (RP) or age-related macular degeneration (AMD). Under local anesthesia, different stimulating electrodes were inserted through the eyewall and positioned over the surface of the retina. Subjects' psychophysical responses to electrical stimulation were recorded. Subjects perceived simple forms in response to pattern electrical stimulation of the retina. A non-flickering perception was created with stimulating frequencies between 40 and 50 Hz. The stimulation threshold was dependent on the targeted retinal area (macular versus extramacular). (+info)A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. (7/306)
AIMS: To assess whether fexofenadine in a range of doses from 80 to 180 mg has any disruptive effects on aspects of psychomotor and cognitive function in comparison with placebo, loratadine and promethazine, an antihistamine known to produce psychomotor and cognitive impairment. METHODS: Twenty-four healthy volunteers received fexofenadine 80 mg, 120 mg and 180 mg, loratadine 10 mg, promethazine 30 mg (as a positive internal control) and placebo in a six-way crossover, double-blind study. Following each dose, subjects were required to perform a series of tests of cognitive function and psychomotor performance at 1.5, 3, 6, 9, 12 and 24 h post dose. The test battery included critical flicker fusion (CFF), choice reaction time (CRT) and assessment of subjective sedation (LARS). Overall levels of activity were monitored by means of wrist mounted actigraphs throughout each of the 24 h experimental periods. RESULTS: Fexofenadine at all doses tested was not statistically different from placebo in any of the tests used and loratadine did not cause any significant impairment of cognitive function. Significant impairments were found following promethazine. Promethazine caused a significant reduction in CFF threshold and this effect was evident up to 12 h post dose (P<0.05). There was a significant increase in recognition reaction time at 3 and 6 h post promethazine administration, and the drug caused a significant (P<0. 002) increase in the percentage of 'sleep-like' activity from actigraph records during the daytime. CONCLUSIONS: Fexofenadine at doses up to 180 mg appears free from disruptive effects on aspects of psychomotor and cognitive function in a study where the psychometric assessments have been shown to be sensitive to impairment, as evidenced by the effects of the verum control promethazine 30 mg. (+info)Spatial and temporal vision in patients treated for bilateral congenital cataracts. (8/306)
Using the method of limits, we measured spatial and temporal vision in 13 children who had been deprived of patterned visual input during infancy until they were treated for dense central cataracts in both eyes. Spatial vision was assessed with vertical sine-wave gratings, and temporal vision was assessed with an unpatterned luminance field sinusoidally modulated over time. Under these testing conditions, spatial contrast sensitivity at low and medium spatial frequencies (0.33-2 c deg-1) was within normal limits, but sensitivity at higher spatial frequencies and grating acuity were reduced on average by 1.3 and 0.5 log units, respectively. Temporal vision was affected less severely, with losses in sensitivity only for low temporal frequencies (5 and 10 Hz), which averaged 0.4 log units. Thus, spatial and temporal vision are likely mediated by different neural mechanisms, that are differentially affected by deprivation. (+info)Flicker Fusion is the frequency at which an intermittent light stimulus appears to be completely steady or continuous to the average human observer. In other words, it is the rate at which a flickering light source transitions from being perceived as distinct flashes to a smooth and constant emission of light. The exact threshold can vary depending on factors such as the intensity of the light, its size, and the observer's visual acuity.
Flicker Fusion has important implications in various fields, including visual perception research, display technology, and neurology. In clinical settings, assessing a patient's flicker fusion threshold can help diagnose or monitor conditions affecting the nervous system, such as multiple sclerosis or migraines.
Oxazepam is a benzodiazepine medication that is primarily used to treat anxiety disorders and symptoms such as sleeplessness and irritability. It works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits the activity of certain neurons in the brain, producing a calming effect.
In medical terms, oxazepam can be defined as follows:
Oxazepam is a Schedule IV controlled substance, indicating that it has a potential for abuse and dependence. It is available in tablet form and is typically taken two to four times per day. Common side effects of oxazepam include drowsiness, dizziness, and weakness. More serious side effects can include memory problems, confusion, and difficulty breathing.
It's important to note that oxazepam should only be used under the supervision of a healthcare provider, as it can have significant risks and interactions with other medications. It is not recommended for use in pregnant women or those with a history of substance abuse.
Hypnotics and sedatives are classes of medications that have depressant effects on the central nervous system, leading to sedation (calming or inducing sleep), reduction in anxiety, and in some cases, decreased awareness or memory. These agents work by affecting the neurotransmitter GABA (gamma-aminobutyric acid) in the brain, which results in inhibitory effects on neuronal activity.
Hypnotics are primarily used for the treatment of insomnia and other sleep disorders, while sedatives are often prescribed to manage anxiety or to produce a calming effect before medical procedures. Some medications can function as both hypnotics and sedatives, depending on the dosage and specific formulation. Common examples of these medications include benzodiazepines (such as diazepam and lorazepam), non-benzodiazepine hypnotics (such as zolpidem and eszopiclone), barbiturates, and certain antihistamines.
It is essential to use these medications under the guidance of a healthcare professional, as they can have potential side effects, such as drowsiness, dizziness, confusion, and impaired coordination. Additionally, long-term use or high doses may lead to tolerance, dependence, and withdrawal symptoms upon discontinuation.
Psychomotor performance refers to the integration and coordination of mental processes (cognitive functions) with physical movements. It involves the ability to perform complex tasks that require both cognitive skills, such as thinking, remembering, and perceiving, and motor skills, such as gross and fine motor movements. Examples of psychomotor performances include driving a car, playing a musical instrument, or performing surgical procedures.
In a medical context, psychomotor performance is often used to assess an individual's ability to perform activities of daily living (ADLs) and instrumental activities of daily living (IADLs), such as bathing, dressing, cooking, cleaning, and managing medications. Deficits in psychomotor performance can be a sign of neurological or psychiatric disorders, such as dementia, Parkinson's disease, or depression.
Assessment of psychomotor performance may involve tests that measure reaction time, coordination, speed, precision, and accuracy of movements, as well as cognitive functions such as attention, memory, and problem-solving skills. These assessments can help healthcare professionals develop appropriate treatment plans and monitor the progression of diseases or the effectiveness of interventions.
Anti-anxiety agents, also known as anxiolytics, are a class of medications used to manage symptoms of anxiety disorders. These drugs work by reducing the abnormal excitement in the brain and promoting relaxation and calmness. They include several types of medications such as benzodiazepines, azapirone, antihistamines, and beta-blockers.
Benzodiazepines are the most commonly prescribed anti-anxiety agents. They work by enhancing the inhibitory effects of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain, which results in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. Examples of benzodiazepines include diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan), and clonazepam (Klonopin).
Azapirones are a newer class of anti-anxiety agents that act on serotonin receptors in the brain. Buspirone (Buspar) is an example of this type of medication, which has fewer side effects and less potential for abuse compared to benzodiazepines.
Antihistamines are medications that are primarily used to treat allergies but can also have anti-anxiety effects due to their sedative properties. Examples include hydroxyzine (Vistaril, Atarax) and diphenhydramine (Benadryl).
Beta-blockers are mainly used to treat high blood pressure and heart conditions but can also help manage symptoms of anxiety such as rapid heartbeat, tremors, and sweating. Propranolol (Inderal) is an example of a beta-blocker used for this purpose.
It's important to note that anti-anxiety agents should be used under the guidance of a healthcare professional, as they can have side effects and potential for dependence or addiction. Additionally, these medications are often used in combination with psychotherapy and lifestyle modifications to manage anxiety disorders effectively.
Reaction time, in the context of medicine and physiology, refers to the time period between the presentation of a stimulus and the subsequent initiation of a response. This complex process involves the central nervous system, particularly the brain, which perceives the stimulus, processes it, and then sends signals to the appropriate muscles or glands to react.
There are different types of reaction times, including simple reaction time (responding to a single, expected stimulus) and choice reaction time (choosing an appropriate response from multiple possibilities). These measures can be used in clinical settings to assess various aspects of neurological function, such as cognitive processing speed, motor control, and alertness.
However, it is important to note that reaction times can be influenced by several factors, including age, fatigue, attention, and the use of certain medications or substances.
The double-blind method is a study design commonly used in research, including clinical trials, to minimize bias and ensure the objectivity of results. In this approach, both the participants and the researchers are unaware of which group the participants are assigned to, whether it be the experimental group or the control group. This means that neither the participants nor the researchers know who is receiving a particular treatment or placebo, thus reducing the potential for bias in the evaluation of outcomes. The assignment of participants to groups is typically done by a third party not involved in the study, and the codes are only revealed after all data have been collected and analyzed.
Membrane fusion is a fundamental biological process that involves the merging of two initially separate lipid bilayers, such as those surrounding cells or organelles, to form a single continuous membrane. This process plays a crucial role in various physiological events including neurotransmitter release, hormone secretion, fertilization, viral infection, and intracellular trafficking of proteins and lipids. Membrane fusion is tightly regulated and requires the participation of specific proteins called SNAREs (Soluble NSF Attachment Protein REceptors) and other accessory factors that facilitate the recognition, approximation, and merger of the membranes. The energy required to overcome the repulsive forces between the negatively charged lipid headgroups is provided by these proteins, which undergo conformational changes during the fusion process. Membrane fusion is a highly specific and coordinated event, ensuring that the correct membranes fuse at the right time and place within the cell.
Cell fusion is the process by which two or more cells combine to form a single cell with a single nucleus, containing the genetic material from all of the original cells. This can occur naturally in certain biological processes, such as fertilization (when a sperm and egg cell fuse to form a zygote), muscle development (where multiple muscle precursor cells fuse together to create multinucleated muscle fibers), and during the formation of bone (where osteoclasts, the cells responsible for breaking down bone tissue, are multinucleated).
Cell fusion can also be induced artificially in laboratory settings through various methods, including chemical treatments, electrical stimulation, or viral vectors. Induced cell fusion is often used in research to create hybrid cells with unique properties, such as cybrid cells (cytoplasmic hybrids) and heterokaryons (nuclear hybrids). These hybrid cells can help scientists study various aspects of cell biology, genetics, and disease mechanisms.
In summary, cell fusion is the merging of two or more cells into one, resulting in a single cell with combined genetic material. This process occurs naturally during certain biological processes and can be induced artificially for research purposes.